REACH: study protocol of a randomised trial of rehabilitation very early in congenital hemiplegia

Abstract

Objectives: Congenital hemiplegia is the most common form of cerebral palsy (CP). Children with unilateral CP show signs of upper limb asymmetry by 8 months corrected age (ca) but are frequently not referred to therapy until after 12 months ca. This study compares the efficacy of infant-friendly modified constraint-induced movement therapy (Baby mCIMT) to infant friendly bimanual therapy (Baby BIM) on upper limb, cognitive and neuroplasticity outcomes in a multisite randomised comparison trial.; Methods and Analysis: 150 infants (75 in each group), aged between 3 and 6 months ca, with asymmetric brain injury and clinical signs of upper extremity asymmetry will be recruited. Children will be randomised centrally to receive equal doses of either Baby mCIMT or Baby BIM. Baby mCIMT comprises restraint of the unimpaired hand using a simple restraint (eg, glove, sock), combined with intensive parent implemented practice focusing on active use of the impaired hand in a play-based context. In contrast, Baby BIM promotes active play requiring both hands in a play-based context. Both interventions will be delivered by parents at home with monthly home visits and interim telecommunication support by study therapists. Assessments will be conducted at study entry; at 6, 12 months ca immediately postintervention (primary outcome) and 24 months ca (retention). The primary outcome will be the Mini-Assisting Hand Assessment. Secondary outcomes include the Bayley Scale for Infant and Toddler Development (cognitive and motor domains) and the Hand Assessment of Infants. A subset of children will undertake MRI scans at 24 months ca to evaluate brain lesion severity and brain (re)organisation after intervention.; Ethics and Dissemination: Full ethical approvals for this study have been obtained from the relevant sites. The findings will be disseminated in peer-reviewed publications.; Trial Registration Number: Australian and New Zealand Clinical Trials Registry: ACTRN12615000180516, Pre results. (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)BMC Pediatr. 2014 Jun 05;14:141. (PMID: 24903062); Health Psychol. 2004 Sep;23(5):443-51. (PMID: 15367063); Behav Brain Res. 2000 Oct;115(1):9-18. (PMID: 10996403); Front Neurol. 2015 Jan 06;5:281. (PMID: 25610423); Ann Intern Med. 2013 Feb 5;158(3):200-7. (PMID: 23295957); AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2208-14. (PMID: 23620070); J Neurosci. 2012 Jul 4;32(27):9265-76. (PMID: 22764234); Pediatrics. 2014 Jan;133(1):e175-204. (PMID: 24366991); J Rehabil Med. 2009 Nov;41(11):886-91. (PMID: 19841839); Res Dev Disabil. 2012 Jan-Feb;33(1):240-50. (PMID: 22093670); Dev Med Child Neurol. 2011 Apr;53(4):313-20. (PMID: 21401585); Dev Med Child Neurol. 2000 Dec;42(12):816-24. (PMID: 11132255); Eur J Paediatr Neurol. 2008 Jan;12(1):24-31. (PMID: 17604195); Dev Med Child Neurol. 1997 Apr;39(4):214-23. (PMID: 9183258); J Rehabil Med. 2014 Jul;46(7):609-15. (PMID: 24940792); Phys Ther. 2016 Aug;96(8):1287-98. (PMID: 26939605); Res Dev Disabil. 2011 Nov-Dec;32(6):2820-8. (PMID: 21700416); Neuroimage Clin. 2015 Apr 09;8:104-9. (PMID: 26106533); Dev Med Child Neurol. 2014 Sep;56(9):839-45. (PMID: 24750109); Dev Med Child Neurol. 2007 Nov;49(11):806. (PMID: 17979856); Pediatrics. 2014 Aug;134(2):e444-53. (PMID: 25070300); Dev Med Child Neurol. 2010 Aug;52(8):767-72. (PMID: 19863639); Neurology. 2004 Mar 23;62(6):851-63. (PMID: 15037681); Ann Neurol. 2007 Nov;62(5):493-503. (PMID: 17444535); Dev Med Child Neurol. 2015 Apr;57 Suppl 2:37-41. (PMID: 25690115); Eur J Paediatr Neurol. 2013 Mar;17(2):192-8. (PMID: 23062755); BMJ. 2014 Mar 07;348:g1687. (PMID: 24609605); Early Hum Dev. 2010 Jan;86(1):1-5. (PMID: 20004536); Phys Occup Ther Pediatr. 2016 Aug;36(3):305-29. (PMID: 26861242); Dev Med Child Neurol. 2007 Feb;49(2):144-51. (PMID: 17254004); Disabil Rehabil. 2014;36(5):434-40. (PMID: 23713990); Ann Neurol. 2004 Dec;56(6):854-63. (PMID: 15562409); J Pediatr. 1999 Aug;135(2 Pt 1):153-61. (PMID: 10431108); Dev Med Child Neurol. 2014 Feb;56(2):125-37. (PMID: 24266735); Dev Med Child Neurol. 2016 Mar;58(3):240-5. (PMID: 26306473); BMJ Open. 2013 Feb 14;3(2):null. (PMID: 23418301); AJNR Am J Neuroradiol. 2009 Jan;30(1):125-31. (PMID: 18832662); Brain. 2011 Jun;134(Pt 6):1591-609. (PMID: 21482550); Med Clin (Barc). 2011 Jul 23;137(5):213-5. (PMID: 21239025); Ann Neurol. 2001 Mar;49(3):320-7. (PMID: 11261506); Dev Med Child Neurol. 2005 Apr;47(4):266-75. (PMID: 15832550); Pediatr Radiol. 2012 Oct;42(10):1169-82. (PMID: 22903761); Brain Connect. 2011;1(4):309-16. (PMID: 22432420); Dev Psychobiol. 2012 May;54(4):372-82. (PMID: 22487940); Behav Res Ther. 1995 Mar;33(3):335-43. (PMID: 7726811); Lancet. 1997 May 10;349(9062):1361-3. (PMID: 9149699); Dev Med Child Neurol. 2006 Jul;48(7):549-54. (PMID: 16780622); N Engl J Med. 2006 Aug 17;355(7):685-94. (PMID: 16914704); Image J Nurs Sch. 1998;30(2):179-84. (PMID: 9775562); Dev Med Child Neurol. 2004 Jul;46(7):461-7. (PMID: 15230459); Dev Med Child Neurol. 2011 Sep;53 Suppl 4:9-13. (PMID: 21950387); Phys Occup Ther Pediatr. 2013 Nov;33(4):467-83. (PMID: 23611310); Aust Occup Ther J. 2009 Feb;56(1):16-23. (PMID: 20854485); Dev Med Child Neurol. 2010 Apr;52(4):352-7. (PMID: 19583744); Disabil Rehabil. 2011;33(21-22):2006-12. (PMID: 21332299); Dev Med Child Neurol. 2006 Jun;48(6):424-8. (PMID: 16700931); Dev Psychol. 2010 Jan;46(1):129-38. (PMID: 20053012); Dev Med Child Neurol. 2017 Jan;59(1):72-78. (PMID: 27273427); Dev Med Child Neurol. 2000 May;42(5):292-6. (PMID: 10855648). Linking ISSN: 20446055. Subset: MEDLINE; Date of Electronic Publication: 2017 Sep 18. ; Original Imprints: Publication: [Londo ] : BMJ Publishing Group Ltd, 2011- <br />